NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme
Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) Programme

NCT00359047

UnknownNA

Sponsor: CHU de Quebec-Universite Laval

Conditions: Osteoporosis

Interventions: Documentation, Video

Countries: Canada

The aim of the ROCQ programme is to improve the use of evidence based osteoporosis diagnostic and treatment strategies for women 50 years and over who have suffered a fragility fracture. This objective will be achieved by concentrating on a realistic evaluation of the present diagnosis and treatment rate of osteoporosis following a fragility fracture and comparing it to an optimal situation (care gap) and proposing interventions that promote new approaches to treating osteoporosis by health professionals as well as providing targeted interventions for the patient. The efficacy of these interventions will be evaluated using a randomized control design.

Eligibility overview

Sex: FEMALE

Age: 50 Years to

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Female, aged 50 years and over.
* Not residing in a long-term care hospital before the fracture.
* Able to understand the programme information and consent form.
* Must voluntarily accept to participate in this programme and sign the consent form.
* Participants must have a fragility or traumatic fracture of one of the following sites: wrist, forearm, humerus, scapula, clavicle, sternum, thoracic or lumbar vertebrae, pelvis, sacrum, hip, femur, proximal and distal tibia, fibula (including ankle), and foot.
* Participants must be able to answer the questionnaires via phone interviews

Exclusion Criteria:

* Unable to understand the purpose of the programme.
* Participants with a traumatic fracture of one of the following sites: cervical, skull and face, hand and finger, toe, metatarsus, and patella.
* Pathological fracture.
* Women currently participating in a clinical trial requiring them to take a medication for osteoporosis.
Locations (1)
  • Québec, Quebec, Canada